Abrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage display
about
Specific in vivo knockdown of protein function by intrabodiesBlockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirusProteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-GlycosylationMolecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in miceIntrabodies against the Polysialyltransferases ST8SiaII and ST8SiaIV inhibit Polysialylation of NCAM in rhabdomyosarcoma tumor cells.Adult human sarcomas. II. Medical oncology.Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.Recent Advances with ER Targeted Intrabodies.Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor.Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability.Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages.Synthetic Mimetics of the gp130 Binding Site for Viral Interleukin-6 as Inhibitors of the vIL-6-gp130 InteractionTargeted Intracellular Delivery of Antibodies: The State of the Art
P2860
Q26801077-2F9288B1-C9FC-44AD-97DD-585BD9F372ACQ27486045-3EC9C10E-130E-468B-A18E-985749BA68C6Q28468416-87F43638-F563-45D7-81E0-C459CA4F81A2Q34013830-DA809EC0-24E6-4E3D-A90F-D694745A45A8Q35550033-E216384B-DAFD-499B-B95F-EB53FDDC18A9Q36018434-0626B9D1-25BD-4212-9B5D-13A0CE6E390DQ36370665-31869932-E120-4731-BABF-708A782C373BQ36731430-0A18BC2C-C1BD-4D77-9997-B165A8484901Q37033410-C22FD461-4856-43CC-91B6-56E3875A4E76Q37136785-DD7B3ACD-6379-4270-8CD1-3338BA1C426AQ38058509-36E5FB07-118D-460E-A18F-0F2938DF128AQ38861174-867F90D0-894F-41EB-B709-3C426170DB25Q41839982-D608C111-F1F7-4332-BA44-6B9492D6BB14Q42052945-FEFC7114-AB22-4101-8F96-FB258ADB35A9Q45207632-5BA02AFA-06F8-4EC0-8A6F-BA9200428775Q57339910-F3B6E0BB-0530-4E65-AFAB-FB7120A23BB6Q58566968-B2567495-BE18-46F9-97D5-377A37E44639
P2860
Abrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage display
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Abrogation of viral interleuki ...... body selected by phage display
@ast
Abrogation of viral interleuki ...... body selected by phage display
@en
Abrogation of viral interleukin-6
@nl
type
label
Abrogation of viral interleuki ...... body selected by phage display
@ast
Abrogation of viral interleuki ...... body selected by phage display
@en
Abrogation of viral interleukin-6
@nl
prefLabel
Abrogation of viral interleuki ...... body selected by phage display
@ast
Abrogation of viral interleuki ...... body selected by phage display
@en
Abrogation of viral interleukin-6
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Abrogation of viral interleuki ...... body selected by phage display
@en
P2093
Björn Rabe
Enge Sudarman
Ingo Bussmeyer
Joachim Grötzinger
Jürgen Scheller
Marina Kovaleva
Udo Conrad
P2860
P304
P356
10.1128/JVI.00420-06
P577
2006-09-01T00:00:00Z